Home  >  TopNews
Msc_Apr23 .
you can get e-magazine links on WhatsApp. Click here
  DoP study shows 58% of CROs in India are small to medium size,   November 30, 2023
  DoP study recommends govt to exempt CRO services from GST,   November 24, 2023
  SEC recommends permission for phase I trial of Cadila Pharma's VZV vaccine,   September 22, 2023
  India's rising profile in clinical trials sparks urgency to raise public awareness: GlobalData,   July 26, 2023
  SEC asks SII to submit revised phase III trial protocol for consideration of its cervical cancer vaccine Cervavac,   May 29, 2023
  Amending NDCTR, 2019 to lay down rules for registration will bring in added transparency in operations: CROs,   May 17, 2023
  India turns out to be a responsive market for clinical data management for clinical trials engagement,   April 15, 2023
  Eyestem to submit data for approval of phase 2a first-in-human study to DCGI for Eyesight RPE for dry AMD,   March 22, 2023
  SEC recommends waiver of local phase III and IV trials for Sanofi's orphan drug to treat Pompe disease,   January 30, 2023
  SEC recommends to waive off Phase IV study on Tocilizumab Injection for GCA,   January 20, 2023
  SEC seeks clinical trial data on Indians for approval of AstraZeneca’s breast cancer drug trastuzumab deruxtecan,   November 28, 2022
  MSF releases clinical trial transparency policy to promote equity in biomedical R&D ecosystem,   November 15, 2022
  India set for large-scale clinical research & trials structured in a coordinated and collaborative manner,   October 01, 2022
  Clinical data disclosure critical for success of Bharat Biotech’s Covid-19 intranasal vaccine: GlobalData,   August 27, 2022
  SEC recommends protocol amendment for GSK's stalled RSV maternal vaccine trial,   June 24, 2022
  ICMR set to develop centres for phase I clinical trial,   June 13, 2022
  SEC asks Roche to submit documentary evidence and efficacy results on two indications of anti-cancer drug atezolizumab,   May 21, 2022
  SEC recommends granting permission to Novartis for phase III b trial of inclisiran,   May 19, 2022
  SEC asks SII and ICMR to submit combined view on approval of TB testing product C-Tb,   April 19, 2022
  Parliamentary panel asks ICMR to work with pharma industry to regain trust on clinical trials,   April 12, 2022

Pharma live expo
Close Open
Copyright © 2023 Saffron Media Pvt. Ltd |